AApoAIV amyloidosis

AApoAIV amyloidosis is an extremely rare form of amyloidosis caused by abnormal deposits of a protein called apolipoprotein A-IV (ApoA-IV) in body tissues. Amyloidosis is a group of diseases where misfolded proteins build up in organs and interfere with their normal function. In AApoAIV amyloidosis, the ApoA-IV protein forms insoluble fibrils that accumulate primarily in the kidneys, but can also affect the heart and other organs over time. The most common symptom is progressive kidney disease, which may eventually lead to kidney failure. Some patients also develop heart problems due to amyloid deposits in heart tissue. Because the disease progresses slowly, many people may not notice symptoms until significant organ damage has already occurred. Symptoms can include swelling in the legs, fatigue, shortness of breath, and changes in urine output. There is currently no cure for AApoAIV amyloidosis. Treatment focuses on managing symptoms and protecting organ function. This may include medications to control blood pressure and protect the kidneys, as well as treatments for heart complications if they arise. In advanced kidney disease, dialysis or kidney transplantation may be necessary. Because this condition is so rare, much of the medical understanding comes from small case series, and research is ongoing to better understand the disease and develop targeted therapies. The disease is also sometimes referred to as apolipoprotein A-IV amyloidosis.

Bring these to your next appointment

• Q1.How much has the amyloid affected my kidneys and are any other organs involved?,How often should I have blood and urine tests to monitor my kidney function?,Should I have genetic testing, and should my family members be tested too?,What dietary changes should I make to protect my kidneys?,Are there any clinical trials or new treatments being studied for this type of amyloidosis?,At what point would I need to consider dialysis or a kidney transplant?,Should I see a cardiologist to check for heart involvement?

Common questions about AApoAIV amyloidosis